SCHEMBL3489600

SCHEMBL3489600

Cn1nc(C(F)(F)F)cc1-c1ccc(F)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.55
PTGS1 P23219 9/20 0.55
ALOX5 P09917 1/20 0.52
STIM1 Q13586 1/20 0.50
ORAI1 Q96D31 1/20 0.50
PRMT5 O14744 1/20 0.47
WDR77 Q9BQA1 1/20 0.47
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14561938 0.86 PTGS2 (0.55) PTGS2PTGS1ALOX5STIM1ORAI1
SCHEMBL10202049 0.85 PTGS2 (0.51) PTGS2PTGS1ALOX5STIM1ORAI1
SCHEMBL21332382 0.85 PTGS2 (0.52) PTGS2PTGS1ALOX5STIM1ORAI1
SCHEMBL17437283 0.85 PTGS2 (0.65) PTGS2PTGS1ALOX5STIM1ORAI1
SCHEMBL14879533 0.85 PTGS2 (0.57) PTGS2PTGS1ALOX5STIM1ORAI1
SCHEMBL14879424 0.81 PTGS2 (0.51) PTGS2PTGS1ALOX5STIM1ORAI1
SCHEMBL16487838 0.81 PTGS1 (0.51) PTGS2PTGS1ALOX5STIM1ORAI1
SCHEMBL22643385 0.81 PTGS2 (0.51) PTGS2PTGS1ALOX5STIM1ORAI1
SCHEMBL31375606 0.81 PTGS2 (0.55) PTGS2PTGS1ALOX5STIM1ORAI1
SCHEMBL31375564 0.81 PDPK1 (0.54) PTGS2PTGS1ALOX5STIM1ORAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100094000-A1 PYRAZOLE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-15 US disclosed
US-20100094000-A1 PYRAZOLE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-15 US disclosed
US-20100094000-A1 PYRAZOLE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100094000-A1 PYRAZOLE COMPOUNDS NR3C2, MC2R, NR3C1 PTGS2 737/4885PTGS1 591/4885ALOX5 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.